Drug development in the era of precision medicine in oncology—Clues beyond randomization
@article{CCO68056, author = {Pauline du Rusquec and Thomas Filleron and Christophe Le Tourneau}, title = {Drug development in the era of precision medicine in oncology—Clues beyond randomization}, journal = {Chinese Clinical Oncology}, volume = {10}, number = {3}, year = {2021}, keywords = {}, abstract = {}, issn = {2304-3873}, url = {https://cco.amegroups.org/article/view/68056} }